Kohlberg & Co to collect recap bids for PCI Pharma later in February, sources say

Jefferies launched the recap process in early January for PCI Pharma, which generates $500m of EBITDA.

Kohlberg & Company is expected to collect bids at the end of February in a recapitalization process of PCI Pharma Services, a pharmaceutical contract development and manufacturing organization, sources familiar with the matter told PE Hub.

The Mount Kisco, New York-headquartered private equity firm is expected to see one or more new investors join with the firm to fund growth initiatives for the global contract development and manufacturing organization, the sources said.